S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
The Odds Are High Costco Will Declare a Special Dividend Soon 
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Stock market today: Wall Street moderately lower as anxiety over interest rates persists
Would Buffett Approve of This Growth Strategy? (Ad)
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Low Beta Stocks To Offset A Possible Hard Landing
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
The Odds Are High Costco Will Declare a Special Dividend Soon 
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Stock market today: Wall Street moderately lower as anxiety over interest rates persists
Would Buffett Approve of This Growth Strategy? (Ad)
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Low Beta Stocks To Offset A Possible Hard Landing
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
The Odds Are High Costco Will Declare a Special Dividend Soon 
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Stock market today: Wall Street moderately lower as anxiety over interest rates persists
Would Buffett Approve of This Growth Strategy? (Ad)
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Low Beta Stocks To Offset A Possible Hard Landing
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
The Odds Are High Costco Will Declare a Special Dividend Soon 
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Stock market today: Wall Street moderately lower as anxiety over interest rates persists
Would Buffett Approve of This Growth Strategy? (Ad)
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Low Beta Stocks To Offset A Possible Hard Landing
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Forecast, Price & News

$0.12
0.00 (0.00%)
(As of 09/27/2023 ET)
Compare
Today's Range
$0.12
▼
$0.13
50-Day Range
$0.11
▼
$0.24
52-Week Range
$0.11
▼
$0.98
Volume
912,464 shs
Average Volume
3.43 million shs
Market Capitalization
$1.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

SXTC stock logo

About China SXT Pharmaceuticals (NASDAQ:SXTC) Stock

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

SXTC Price History

SXTC Stock News Headlines

September 7, 2023 | investorplace.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?
August 25, 2023 | seekingalpha.com
SXTC China SXT Pharmaceuticals, Inc.
September 28, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
August 21, 2023 | markets.businessinsider.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
August 2, 2023 | finance.yahoo.com
China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
May 10, 2023 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
March 29, 2023 | finance.yahoo.com
Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop
January 10, 2023 | reuters.com
China says talks to include Paxlovid in its insurance drug list fail
September 28, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
January 5, 2023 | benzinga.com
China SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News Summary
May 18, 2022 | seekingalpha.com
China SXT Pharmaceuticals announces 1-for-20 reverse stock split
March 29, 2022 | investorplace.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today?
March 29, 2022 | seekingalpha.com
China SXT Pharmaceuticals climbs on heavy volume
March 15, 2022 | seekingalpha.com
China SXT Pharmaceuticals to raise $2.8M in convertible promissory note offering
March 14, 2022 | benzinga.com
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
January 20, 2022 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
January 20, 2022 | finance.yahoo.com
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).
January 18, 2022 | finance.yahoo.com
China SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep Discount
January 18, 2022 | seekingalpha.com
China SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offering
January 18, 2022 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
January 14, 2022 | seekingalpha.com
China SXT Pharma announces proposed public offering of shares, prefunded warrants
January 14, 2022 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
January 14, 2022 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin
October 18, 2021 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection
February 19, 2021 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split
February 11, 2021 | apnews.com
China SXT Pharmaceuticals, Inc. Enters into Non-Binding LOI to Acquire Jiangsu Renji Pharmaceutical Chain Co., Ltd.
October 21, 2020 | nasdaq.com
China SXT Pharmaceuticals, Inc. Ordinary Shares (SXTC)
See More Headlines
Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SXTC Company Calendar

Today
9/28/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SXTC
CUSIP
N/A
CIK
1723980
Web
www.sxtchina.com
Phone
8652386299087
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.35
Quick Ratio
1.31

Sales & Book Value

Annual Sales
$1.97 million
Price / Sales
0.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.28 per share
Price / Book
0.10

Miscellaneous

Outstanding Shares
11,430,000
Free Float
10,982,000
Market Cap
$1.42 million
Optionable
Not Optionable
Beta
0.86
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Feng Zhou (Age 31)
    Chairman & CEO
    Comp: $50k
  • Mr. Xiaodong Pan (Age 45)
    Chief Financial Officer
    Comp: $50k
  • Mr. Jun Zheng (Age 45)
    Exec. Director

Key Competitors

View All Competitors













SXTC Stock - Frequently Asked Questions

How have SXTC shares performed in 2023?

China SXT Pharmaceuticals' stock was trading at $0.5420 on January 1st, 2023. Since then, SXTC stock has decreased by 77.0% and is now trading at $0.1246.
View the best growth stocks for 2023 here.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 575,400 shares, an increase of 99.7% from the August 31st total of 288,100 shares. Based on an average daily trading volume, of 4,040,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.6% of the shares of the company are short sold.
View China SXT Pharmaceuticals' Short Interest.

When is China SXT Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our SXTC earnings forecast.

When did China SXT Pharmaceuticals' stock split?

China SXT Pharmaceuticals shares reverse split on Thursday, May 19th 2022. The 1-20 reverse split was announced on Thursday, May 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include iBio (IBIO), Remark (MARK), Aytu BioPharma (AYTU), BIMI International Medical (BIMI), My Size (MYSZ), Nabriva Therapeutics (NBRV), Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE).

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $0.12.

How much money does China SXT Pharmaceuticals make?

China SXT Pharmaceuticals (NASDAQ:SXTC) has a market capitalization of $1.42 million and generates $1.97 million in revenue each year.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The official website for the company is www.sxtchina.com. The company can be reached via phone at 8652386299087 or via email at ir@sxtchina.com.

This page (NASDAQ:SXTC) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -